Silvio Inzucchi, Stefan Anker
Welcome and introduction
All facutly; moderated by Silvio Inzucchi
Cardiovascular mortality in T2D: old challenges, new opportunities Panel discussion
Optimising T2D management: what’s driving treatment decisions?
Advancing patient care in T2D: what does the emerging evidence tell us?
Stefan Anker, Merlin Thomas
Exploring the effects of SGLT2 inhibition in ongoing clinical trials
All faculty; moderated by Silvio Inzucchi
Rethinking treatment decisions to optimise patient outcomes Panel discussion and audience Q&A